No Data
Fudan Zhangjiang 2024 Annual Results Forecast Announcement
Fudan-Zhangjiang Bio-Pharma Expects Up to 68% Lower Net Profit in 2024
Express News | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Sees Unaudited Net Profit Attributable RMB35 Mln to RMB52 Mln for Year
FUDANZHANGJIANG: INSIDE INFORMATION / PROFIT WARNING
Announcement Highlights | Wanwu Cloud acquires 100% equity of Zhongzhou Property; UBTECH executives commit not to reduce their Shareholding within 12 months.
C&D INTL GROUP: The cumulative contract sales amount for 2024 is about 103.36 billion yuan, a year-on-year decrease of about 25.1%; SHIMAO SERVICES plans to acquire 33% of Shenzhen Shilu Yuan Environmental for 83.159 million yuan for full ownership.
Selected Announcements | Alibaba's buyback plan still has a remaining amount of 20.7 billion USD; GTJA plans to conduct a stock swap to absorb and merge HAITONG SEC and will send a proposal to the meeting for fundraising support.
In 2024, Qinhuangdao Port's total throughput reached 0.414 billion tons, a year-on-year increase of 5.66%; ZHAOKE OPHTH-B: The National Medical Products Administration accepted the simplified new drug application for NVK002, used to treat worsening myopia in children.
